Search results for: Healthcare Systems
Filter search results
What NHS Trusts Can Do to Reduce Waiting Times for Cancer Treatment
2 January 2020
The NHS Improvement Economics team is part of the Strategy Directorate in NHS Improvement. NHS Improvement aims to implement changes to help improve both quality and efficiency. Recent research by…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
1 September 2019
Antimicrobial resistance (AMR) is a growing public health threat, limiting the ability of health care systems to prevent and treat infections and save lives. In parallel, global antibiotic development pipelines…
OHE in the Spotlight: Summer 2011
22 September 2011
…in emerging market health care systems. With Lou Garrison of University of Washington, Adrian Towse presented at the Industry HTA Learnings session on progress on the HTA emerging markets project…
Waiting Time Policies in the Health Sector
1 June 2016
This OHE Seminar Briefing summarises a seminar given by Professor Luigi Siciliani on waiting time policies in the health sector from an international perspective, and highlights which policies have worked…
International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective
1 May 2015
The OHE undertook an analysis of the uptake of medicines in 13 high income countries. The UK perspective on this was published in November 2014 by the ABPI. OHE has…
OHE’s 50th Celebration: Publications on Tuberculosis Show Constancy and Change
23 August 2012
…more than 100 booklets on various diseases and conditions as part of a series on “current health problems”. Topics included public health issues and health systems challenges – and also…
Value Based Pricing in Sweden: Lessons for Design?
28 November 2012
…beyond the health sector. This may include the value of caregivers’ time and foregone income, a societal cost often poorly recognised in HTA systems. Second, Sweden does not have a…
New Research by OHE and University of Glasgow on cost of QALYs in Scotland
17 December 2012
…the conclusions drawn from it will be of interest to the whole of the UK, given the similarities in the funding of the health care systems, the services they provide…
Changes in Determining Medicines Pricing in France, Germany and the UK
24 January 2013
…being discussed in pricing and reimbursement/HTA systems in France, Germany and the UK. New requirements for health technology assessment in Europe have important implications for markets and for access to…